Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)

V.V. Poltorak; N.A. Kravchun; M.Yu. Gorshunskaya; N.S. Krasova

doi:10.22141/2224-0721.1.57.2014.76425

Mìžnarodnij Endokrinologìčnij Žurnal (Feb 2014)

Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)

V.V. Poltorak,
N.A. Kravchun,
M.Yu. Gorshunskaya,
N.S. Krasova

Affiliations

V.V. Poltorak: State Institution «Institute of Problems of Endocrine Pathology named after V.Ya. Daniylevsky of National Academy of Medical Sciences of Ukraine», Kharkiv
N.A. Kravchun: State Institution «Institute of Problems of Endocrine Pathology named after V.Ya. Daniylevsky of National Academy of Medical Sciences of Ukraine», Kharkiv
M.Yu. Gorshunskaya: Kharkiv Medical Academy of Postgraduate Education, Kharkiv
N.S. Krasova: State Institution «Institute of Problems of Endocrine Pathology named after V.Ya. Daniylevsky of National Academy of Medical Sciences of Ukraine», Kharkiv

DOI: https://doi.org/10.22141/2224-0721.1.57.2014.76425
Journal volume & issue: Vol. 10, no. 1.57
pp. 77 – 89

Abstract

Read online

The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogenic and antithrombotic effects, also an emphasis has been made on the safety of the drug.

Published in Mìžnarodnij Endokrinologìčnij Žurnal

ISSN: 2224-0721 (Print); 2307-1427 (Online)
Publisher: Zaslavsky O.Yu.
Country of publisher: Ukraine
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://iej.zaslavsky.com.ua/index.php/journal

About the journal

Abstract

Keywords